CPHI vs CSGP · rev $4.5M vs P/E 484, rev $2.74B
China Pharma Holdings Inc (CPHI) versus CoStar Group Inc (CSGP) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
CoStar Group Inc (CSGP) is a real estate services company listed on US.
Latest reported CPHI revenue for 2024-12-31 was $4.5M. Net income was -$4.7M. Revenue was down 35.4% from 2023-12-31 to 2024-12-31. CPHI currently screens at market cap $29.0M.
Latest reported CSGP revenue for 2024-12-31 was $2.74B. Net income was $138.7M. Revenue was up 11.5% from 2023-12-31 to 2024-12-31. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
CPHI currently screens at market cap $29.0M. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
Not investment advice. Open the CPHI and CSGP stock pages for the full models.
Not investment advice.